Factors of the PUQE Score
The Pregnancy-Unique Quantification of Emesis (PUQE) score consists of three specific factors: duration of nausea in hours, number of vomiting episodes, and number of retching or dry heaving episodes over a defined time period. 1
Detailed Components of the PUQE Score
The PUQE score evaluates three key symptoms on a 5-point scale (1-5 points each):
Duration of Nausea: How long (in hours) has the patient felt nauseated or sick to the stomach?
- 1 point: Not at all
- 2 points: 1 hour
- 3 points: 2-3 hours
- 4 points: 4-6 hours
- 5 points: >6 hours
Vomiting Episodes: How many times has the patient thrown up or vomited?
- 1 point: No vomiting
- 2 points: 1-2 times
- 3 points: 3-4 times
- 4 points: 5-6 times
- 5 points: ≥7 times
Retching Episodes: How many times has the patient experienced retching or dry heaves without throwing up?
- 1 point: None
- 2 points: 1-2 times
- 3 points: 3-4 times
- 4 points: 5-6 times
- 5 points: ≥7 times
Scoring and Interpretation
The total PUQE score is calculated by summing the points from all three categories:
- Maximum possible score: 15 points
- Severity classification:
- ≤6 points: Mild nausea and vomiting of pregnancy
- 7-12 points: Moderate nausea and vomiting of pregnancy
- ≥13 points: Severe nausea and vomiting of pregnancy 1
Clinical Significance
The PUQE score has been validated through multiple studies and correlates well with:
- Ability to take multivitamin supplements
- Rates of emergency room visits and hospitalizations for NVP
- Quality of life and well-being scores
- Healthcare costs associated with NVP 2
Versions of the PUQE Score
There are two main versions of the PUQE score:
- Original PUQE: Measures symptoms over the previous 12 hours
- PUQE-24: An extended version that measures symptoms over 24 hours, which may better capture the full range of symptoms, especially for women who experience symptoms primarily during sleeping hours 3
The PUQE score is recommended by the American College of Gastroenterology as a tool to guide appropriate treatment decisions for nausea and vomiting during pregnancy and to prevent progression to hyperemesis gravidarum 4.